Literature DB >> 16696022

Calcium binding and concomitant changes in the structure and heat stability of calprotectin (L1 protein).

C F Naess-Andresen1, B Egelandsdal, M K Fagerhol.   

Abstract

Aim-To obtain further data on the structure and conformation of calprotectin, a prominent leucocyte protein found in many species.Methods-The binding of Ca(2+) to calprotectin was studied by means of equilibrium dialysis using (45)Ca as tracer. The thermal stability and denaturation kinetics of calprotectin were studied by means of differential scanning calorimetry. Con-comitant alterations in optical activity resulting from different conditions were measured. A computer program calculated the parameters to fit different models of protein structure. Ultraviolet spectroscopy gave absorbtion spectra. Sedimentation velocity studies and molecular weight determinations by the low speed (sedimentation) equilibrium technique were performed.Results-A maximum of six calcium ions were bound per calprotectin molecule at 0.7 mM calcium chloride. The apparent dissociation constants were calculated. Ca(2+) ions increased the denaturation temperature by 26 degrees K. The enthalpy of denaturation was also increased by Ca(2+). Addition of Ca(2+) to the buffers caused a gradual change in the near UV circular dichroism spectrum, while only minor changes were seen at wavelengths of 210-240 nm. A gradual increase in the sedimentation coefficient was observed on addition of calcium chloride. The extinction coefficient at 279nm was determined: E(279)= 2.53.10(4) M(-1) cm(-1).Conclusions-Calprotectin can bind six calcium ions. Upon binding, the protein shows distinct conformational changes and increased thermal stability. The former may be of importance for its function, while the biological significance of the latter is unknown.

Entities:  

Year:  1995        PMID: 16696022      PMCID: PMC407985          DOI: 10.1136/mp.48.5.m278

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN: 1355-2910


  22 in total

1.  Calcium-dependent complex assembly of the myeloic differentiation proteins MRP-8 and MRP-14.

Authors:  S Teigelkamp; R S Bhardwaj; J Roth; G Meinardus-Hager; M Karas; C Sorg
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

2.  L1, a major granulocyte protein; isolation of high quantities of its subunits.

Authors:  H B Berntzen; M K Fagerhol
Journal:  Scand J Clin Lab Invest       Date:  1990-11       Impact factor: 1.713

3.  Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin.

Authors:  M Steinbakk; C F Naess-Andresen; E Lingaas; I Dale; P Brandtzaeg; M K Fagerhol
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

4.  Circular dichroic analysis of protein conformation: inclusion of the beta-turns.

Authors:  C T Chang; C S Wu; J T Yang
Journal:  Anal Biochem       Date:  1978-11       Impact factor: 3.365

5.  Epidermal and dermal distribution of a myelomonocytic antigen (L1) shared by epithelial cells in various inflammatory skin diseases.

Authors:  T O Gabrielsen; I Dale; P Brandtzaeg; P S Hoel; M K Fagerhol; T E Larsen; P O Thune
Journal:  J Am Acad Dermatol       Date:  1986-08       Impact factor: 11.527

Review 6.  Stability of proteins: small globular proteins.

Authors:  P L Privalov
Journal:  Adv Protein Chem       Date:  1979

7.  Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia.

Authors:  P Brandtzaeg; I Dale; M K Fagerhol
Journal:  Am J Clin Pathol       Date:  1987-06       Impact factor: 2.493

8.  The binding of calcium to a salivary phosphoprotein, protein A, common to human parotid and submandibular secretions.

Authors:  A Bennick
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

9.  Calprotectin (the L1 protein) during surgery in patients with rheumatoid arthritis.

Authors:  H Berner Berntzen; G K Endresen; M K Fagerhol; J Spiechowicz; P Mowinckel
Journal:  Scand J Clin Lab Invest       Date:  1991-11       Impact factor: 1.713

10.  Calmodulin and troponin C: a comparative study of the interaction of mastoparan and troponin I inhibitory peptide [104-115].

Authors:  P J Cachia; J Van Eyk; R H Ingraham; W D McCubbin; C M Kay; R S Hodges
Journal:  Biochemistry       Date:  1986-06-17       Impact factor: 3.162

View more
  11 in total

1.  Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein?

Authors:  M K Fagerhol
Journal:  Clin Mol Pathol       Date:  1996-04

Review 2.  Non-invasive investigation of inflammatory bowel disease.

Authors:  J A Tibble; I Bjarnason
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 3.  Functional and clinical aspects of the myelomonocyte protein calprotectin.

Authors:  B Johne; M K Fagerhol; T Lyberg; H Prydz; P Brandtzaeg; C F Naess-Andresen; I Dale
Journal:  Mol Pathol       Date:  1997-06

4.  Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review.

Authors:  Monica State; Lucian Negreanu; Theodor Voiosu; Andrei Voiosu; Paul Balanescu; Radu Bogdan Mateescu
Journal:  World J Gastroenterol       Date:  2021-04-28       Impact factor: 5.742

Review 5.  Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis.

Authors:  Mariusz A Bromke; Katarzyna Neubauer; Radosław Kempiński; Małgorzata Krzystek-Korpacka
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

6.  What Is a Flare? The Manitoba Living With IBD Study.

Authors:  Kelcie Witges; Kathryn Sexton; Lesley A Graff; Laura E Targownik; Lisa M Lix; Clove Haviva; James Stone; Leigh Anne Shafer; Kathy Vagianos; Charles N Bernstein
Journal:  Inflamm Bowel Dis       Date:  2022-06-03       Impact factor: 7.290

7.  Fecal Calprotectin in Healthy Children Aged 1-4 Years.

Authors:  Qingling Zhu; Feng Li; Junli Wang; Lixiao Shen; Xiaoyang Sheng
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

Review 8.  Calprotectin in inflammatory bowel disease.

Authors:  Fatemeh Khaki-Khatibi; Durdi Qujeq; Mehrdad Kashifard; Soheila Moein; Mahmood Maniati; Mostafa Vaghari-Tabari
Journal:  Clin Chim Acta       Date:  2020-08-18       Impact factor: 3.786

Review 9.  Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease.

Authors:  Kohei Wagatsuma; Yoshihiro Yokoyama; Hiroshi Nakase
Journal:  Life (Basel)       Date:  2021-12-10

10.  Fecal Calprotectin: A Comparison of Two Commercial Enzymoimmunoassays and Study of Fecal Extract Stability at Room Temperature.

Authors:  Delia Acevedo; Maria Pilar Salvador; Javier Girbes; Nuria Estan
Journal:  J Clin Med Res       Date:  2018-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.